North Point Portfolio Managers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$246K Buy
584
+17
+3% +$6.78K 0.04% 68
2026
Q2
$205K Buy
+567
New +$194K 0.03% 79

Other funds holding AMGN

North Point Portfolio Managers's AMGN Position: Q3 2026 in Review

North Point Portfolio Managers increased its Amgen (AMGN) stake by 3% in Q3 2026, buying an estimated $6.78K and bringing the position to 584 shares worth $246K. The position accounts for 0.04% of the portfolio, ranked #68.

North Point Portfolio Managers first reported a position in AMGN in Q2 2026 and has held it in 2 quarters since. 131 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • North Point Portfolio Managers held 584 shares of Amgen worth $246K as of Q3 2026.
  • North Point Portfolio Managers bought 17 Amgen shares in Q3 2026, an estimated $6.78K.
  • Amgen made up 0.04% of North Point Portfolio Managers's portfolio in Q3 2026, its #68 holding.
  • North Point Portfolio Managers first reported a position in Amgen in Q2 2026 and has held it in 2 quarters since.
  • 131 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on North Point Portfolio Managers's 13F filing for Q3 2026, filed 7 Oct 2026.